Rapid Micro Biosystems, Inc. (RPID) Reports In-Line Q3 EPS ; Offers Guidance

Rapid Micro Biosystems, Inc. (NASDAQ: RPID) reported Q3 EPS of ($0.31), in-line with the analyst estimate of ($0.31). Revenue for the quarter came in at $6.1 million versus the consensus estimate of $5.55 million.

GUIDANCE:

Rapid Micro Biosystems, Inc. sees FY2023 revenue of ~$22 million, versus the consensus of $22.26 million.

For earnings history and earnings-related data on Rapid Micro Biosystems, Inc. (RPID) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance